Selected research
Industry Research
Beta-Glucan Nutraceuticals Industry Research Report 2026
Market perspective
The global Beta-Glucan Nutraceuticals market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Beta-Glucan Nutraceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Beta-Glucan Nutraceuticals is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Beta-Glucan Nutraceuticals is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Beta-Glucan Nutraceuticals include Tate & Lyle, Super Beta Glucan, STR Biotech, Lesaffre Group, Kemin Industries, Garuda International, DSM and Ceapro, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Beta-Glucan Nutraceuticals market in terms of revenue (US$ million) and, where applicable, sales volume (tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Beta-Glucan Nutraceuticals Market by Company
Tate & Lyle
Super Beta Glucan
STR Biotech
Lesaffre Group
Kemin Industries
Garuda International
DSM
Ceapro
Beta-Glucan Nutraceuticals Segment by Type
Mushroom Beta Glucan
Yeast Beta Glucan
Cereal Beta Glucan
Others
Beta-Glucan Nutraceuticals Segment by Application
Online Sale
Offline Sale
Beta-Glucan Nutraceuticals Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Beta-Glucan Nutraceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Beta-Glucan Nutraceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Beta-Glucan Nutraceuticals.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Beta-Glucan Nutraceuticals manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Beta-Glucan Nutraceuticals by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Beta-Glucan Nutraceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Mushroom Beta Glucan
- Yeast Beta Glucan
- Cereal Beta Glucan
- Others
Applications
- Online Sale
- Offline Sale
Companies covered
- Tate & Lyle
- Super Beta Glucan
- STR Biotech
- Lesaffre Group
- Kemin Industries
- Garuda International
- DSM
- Ceapro
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Beta-Glucan Nutraceuticals Market Size (2021-2032)
- 2.2.2 Global Beta-Glucan Nutraceuticals Sales (2021-2032)
- 2.2.3 Global Beta-Glucan Nutraceuticals Market Average Price (2021-2032)
- 2.3 Beta-Glucan Nutraceuticals by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Mushroom Beta Glucan
- 2.3.3 Yeast Beta Glucan
- 2.3.4 Cereal Beta Glucan
- 2.3.5 Others
- 2.4 Beta-Glucan Nutraceuticals by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Sale
- 2.4.3 Offline Sale
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Beta-Glucan Nutraceuticals Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Beta-Glucan Nutraceuticals Sales (tons) of Manufacturers (2021-2026)
- 3.3 Global Beta-Glucan Nutraceuticals Revenue of Manufacturers (2021-2026)
- 3.4 Global Beta-Glucan Nutraceuticals Average Price by Manufacturers (2021-2026)
- 3.5 Global Beta-Glucan Nutraceuticals Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Beta-Glucan Nutraceuticals, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Beta-Glucan Nutraceuticals, Product Type & Application
- 3.8 Global Manufacturers of Beta-Glucan Nutraceuticals, Established Date
- 3.9 Global Beta-Glucan Nutraceuticals Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Tate & Lyle
- 4.1.1 Tate & Lyle Company Information
- 4.1.2 Tate & Lyle Business Overview
- 4.1.3 Tate & Lyle Beta-Glucan Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Tate & Lyle Beta-Glucan Nutraceuticals Product Portfolio
- 4.1.5 Tate & Lyle Recent Developments
- 4.2 Super Beta Glucan
- 4.2.1 Super Beta Glucan Company Information
- 4.2.2 Super Beta Glucan Business Overview
- 4.2.3 Super Beta Glucan Beta-Glucan Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Super Beta Glucan Beta-Glucan Nutraceuticals Product Portfolio
- 4.2.5 Super Beta Glucan Recent Developments
- 4.3 STR Biotech
- 4.3.1 STR Biotech Company Information
- 4.3.2 STR Biotech Business Overview
- 4.3.3 STR Biotech Beta-Glucan Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 STR Biotech Beta-Glucan Nutraceuticals Product Portfolio
- 4.3.5 STR Biotech Recent Developments
- 4.4 Lesaffre Group
- 4.4.1 Lesaffre Group Company Information
- 4.4.2 Lesaffre Group Business Overview
- 4.4.3 Lesaffre Group Beta-Glucan Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Lesaffre Group Beta-Glucan Nutraceuticals Product Portfolio
- 4.4.5 Lesaffre Group Recent Developments
- 4.5 Kemin Industries
- 4.5.1 Kemin Industries Company Information
- 4.5.2 Kemin Industries Business Overview
- 4.5.3 Kemin Industries Beta-Glucan Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Kemin Industries Beta-Glucan Nutraceuticals Product Portfolio
- 4.5.5 Kemin Industries Recent Developments
- 4.6 Garuda International
- 4.6.1 Garuda International Company Information
- 4.6.2 Garuda International Business Overview
- 4.6.3 Garuda International Beta-Glucan Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Garuda International Beta-Glucan Nutraceuticals Product Portfolio
- 4.6.5 Garuda International Recent Developments
- 4.7 DSM
- 4.7.1 DSM Company Information
- 4.7.2 DSM Business Overview
- 4.7.3 DSM Beta-Glucan Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 DSM Beta-Glucan Nutraceuticals Product Portfolio
- 4.7.5 DSM Recent Developments
- 4.8 Ceapro
- 4.8.1 Ceapro Company Information
- 4.8.2 Ceapro Business Overview
- 4.8.3 Ceapro Beta-Glucan Nutraceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ceapro Beta-Glucan Nutraceuticals Product Portfolio
- 4.8.5 Ceapro Recent Developments
5 Global Beta-Glucan Nutraceuticals Market Scenario by Region
- 5.1 Global Beta-Glucan Nutraceuticals Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Beta-Glucan Nutraceuticals Sales by Region: 2021-2032
- 5.2.1 Global Beta-Glucan Nutraceuticals Sales by Region: 2021-2026
- 5.2.2 Global Beta-Glucan Nutraceuticals Sales by Region: 2027-2032
- 5.3 Global Beta-Glucan Nutraceuticals Revenue by Region: 2021-2032
- 5.3.1 Global Beta-Glucan Nutraceuticals Revenue by Region: 2021-2026
- 5.3.2 Global Beta-Glucan Nutraceuticals Revenue by Region: 2027-2032
- 5.4 North America Beta-Glucan Nutraceuticals Market Facts & Figures by Country
- 5.4.1 North America Beta-Glucan Nutraceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Beta-Glucan Nutraceuticals Sales by Country (2021-2032)
- 5.4.3 North America Beta-Glucan Nutraceuticals Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Beta-Glucan Nutraceuticals Market Facts & Figures by Country
- 5.5.1 Europe Beta-Glucan Nutraceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Beta-Glucan Nutraceuticals Sales by Country (2021-2032)
- 5.5.3 Europe Beta-Glucan Nutraceuticals Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Beta-Glucan Nutraceuticals Market Facts & Figures by Country
- 5.6.1 Asia Pacific Beta-Glucan Nutraceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Beta-Glucan Nutraceuticals Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Beta-Glucan Nutraceuticals Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Beta-Glucan Nutraceuticals Market Facts & Figures by Country
- 5.7.1 South America Beta-Glucan Nutraceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Beta-Glucan Nutraceuticals Sales by Country (2021-2032)
- 5.7.3 South America Beta-Glucan Nutraceuticals Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Beta-Glucan Nutraceuticals Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Beta-Glucan Nutraceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Beta-Glucan Nutraceuticals Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Beta-Glucan Nutraceuticals Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Beta-Glucan Nutraceuticals Sales by Type (2021-2032)
- 6.1.1 Global Beta-Glucan Nutraceuticals Sales by Type (2021-2032) & (tons)
- 6.1.2 Global Beta-Glucan Nutraceuticals Sales Market Share by Type (2021-2032)
- 6.2 Global Beta-Glucan Nutraceuticals Revenue by Type (2021-2032)
- 6.2.1 Global Beta-Glucan Nutraceuticals Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Beta-Glucan Nutraceuticals Revenue Market Share by Type (2021-2032)
- 6.3 Global Beta-Glucan Nutraceuticals Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Beta-Glucan Nutraceuticals Sales by Application (2021-2032)
- 7.1.1 Global Beta-Glucan Nutraceuticals Sales by Application (2021-2032) & (tons)
- 7.1.2 Global Beta-Glucan Nutraceuticals Sales Market Share by Application (2021-2032)
- 7.2 Global Beta-Glucan Nutraceuticals Revenue by Application (2021-2032)
- 7.2.1 Global Beta-Glucan Nutraceuticals Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Beta-Glucan Nutraceuticals Revenue Market Share by Application (2021-2032)
- 7.3 Global Beta-Glucan Nutraceuticals Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Beta-Glucan Nutraceuticals Value Chain Analysis
- 8.1.1 Beta-Glucan Nutraceuticals Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Beta-Glucan Nutraceuticals Production Mode & Process
- 8.2 Beta-Glucan Nutraceuticals Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Beta-Glucan Nutraceuticals Distributors
- 8.2.3 Beta-Glucan Nutraceuticals Customers
9 Global Beta-Glucan Nutraceuticals Analyzing Market Dynamics
- 9.1 Beta-Glucan Nutraceuticals Industry Trends
- 9.2 Beta-Glucan Nutraceuticals Industry Drivers
- 9.3 Beta-Glucan Nutraceuticals Industry Opportunities and Challenges
- 9.4 Beta-Glucan Nutraceuticals Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst